Navigated to FDA Approval: Sunvozertinib for EGFR Exon 20
Get the app

Log in
Lung Cancer Considered

FDA Approval: Sunvozertinib for EGFR Exon 20

July 15
41 mins

Episode Description

FDA Approval: Sunvozertinib for EGFR Exon 20 by IASLC
See all episodes